↓ Skip to main content

Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial

Overview of attention for article published in BMC Medical Research Methodology, April 2012
Altmetric Badge

Mentioned by

twitter
1 X user

Readers on

mendeley
69 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Results from a blind and a non-blind randomised trial run in parallel: experience from the Estonian Postmenopausal Hormone Therapy (EPHT) Trial
Published in
BMC Medical Research Methodology, April 2012
DOI 10.1186/1471-2288-12-44
Pubmed ID
Authors

Piret Veerus, Krista Fischer, Matti Hakama, Elina Hemminki, The EPHT Trial

Abstract

The Estonian Postmenopausal Hormone Therapy (EPHT) Trial assigned 4170 potential participants prior to recruitment to blind or non-blind hormone therapy (HT), with placebo or non-treatment the respective alternatives. Before having to decide on participation, women were told whether they had been randomised to the blind or non-blind trial. Eligible women who were still willing to join the trial were recruited. After recruitment participants in the non-blind trial (N = 1001) received open-label HT or no treatment, participants in the blind trial (N = 777) remained blinded until the end of the trial. The aim of this paper is to analyse the effect of blinding on internal and external validity of trial outcomes.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 69 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 1%
Unknown 68 99%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 10 14%
Student > Master 9 13%
Researcher 6 9%
Student > Ph. D. Student 4 6%
Professor > Associate Professor 3 4%
Other 8 12%
Unknown 29 42%
Readers by discipline Count As %
Medicine and Dentistry 23 33%
Nursing and Health Professions 6 9%
Neuroscience 2 3%
Agricultural and Biological Sciences 1 1%
Immunology and Microbiology 1 1%
Other 4 6%
Unknown 32 46%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 03 May 2012.
All research outputs
#15,243,120
of 22,664,644 outputs
Outputs from BMC Medical Research Methodology
#1,499
of 2,000 outputs
Outputs of similar age
#102,440
of 161,215 outputs
Outputs of similar age from BMC Medical Research Methodology
#21
of 38 outputs
Altmetric has tracked 22,664,644 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,000 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.2. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 161,215 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 25th percentile – i.e., 25% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 38 others from the same source and published within six weeks on either side of this one. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.